Brief: Entera Bio Ltd Announces Third Quarter 2020 Financial Results And Provides Clinical Update
19/11/2020 11:44
Nov 19 (Reuters) - Entera Bio Ltd ENTX.O :
* ENTERA BIO LTD ANNOUNCES THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CLINICAL UPDATE
* ENTERA BIO LTD - EXPECTS AN OPERATING LOSS OF AT LEAST
$11.4
MILLION FOR YEAR ENDING DECEMBER 31, 2020
* ENTERA BIO LTD - BELIEVES ITS CURRENT CASH POSITION WILL
BE
SUFFICIENT TO FUND ITS OPERATIONS INTO Q2 OF 2021
* ENTERA BIO LTD QTRLY LOSS PER SHARE $0.09
Source text for Eikon: ID:nGNX8CDhYQ
Further company coverage: ENTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement